Medications

US Pfizer, India's Biocon scrap insulin pact

India's largest biotechnology firm, Biocon, and US pharmaceutical giant Pfizer said Tuesday they would scrap a joint plan to sell insulin products, sending Biocon's shares plunging.

Health

A look at where companies stand on marijuana business

When Canada legalized recreational marijuana in October, it emerged as the world leader in the industry—and U.S. companies are scrambling to get in on the action. Uruguay may have been the first country to legalize pot, ...

Medications

Reckitt pays US $1.4bn to settle opioid treatment spat

British consumer health giant Reckitt Benckiser announced Thursday it will pay up to $1.4 billion (1.2 billion euros) to settle a dispute with US authorities over the sale and marketing of an opioid addiction treatment.

page 2 from 4